Viva Biotech Holdings Capital Reinvestment Ratio
Viva Biotech Holdings capital reinvestment ratio. Viva Biotech Holdings (VB0) has a Capital Reinvestment Ratio of 0.32x as of June 2023, meaning it reinvests 0% of its operating cash flow (€158.72 Million) in capital expenditures (€50.80 Million). Check Viva Biotech Holdings total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Viva Biotech Holdings (2016–2024)
Capital reinvestment ratio of Viva Biotech Holdings from 2016 to 2024. This chart tracks Viva Biotech Holdings's Capital Reinvestment Ratio across 9 annual periods. Also explore VB0 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Viva Biotech Holdings Capital Reinvestment Ratio by Year (2016–2024)
Viva Biotech Holdings capital reinvestment ratio by year from 2016 to 2024. For the full cash flow conversion analysis, see VB0 operating cash flow.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.51x | €373.99 Million | €191.67 Million | ▲ +4.6% |
| 2023 | 0.49x | €383.40 Million | €187.84 Million | ▼ -24.1% |
| 2022 | 0.65x | €386.05 Million | €249.33 Million | ▼ -91.1% |
| 2021 | 7.26x | €77.83 Million | €565.18 Million | ▼ -47.1% |
| 2020 | 13.72x | €43.18 Million | €592.62 Million | ▲ +1023.9% |
| 2019 | 1.22x | €46.01 Million | €56.19 Million | ▼ -68.5% |
| 2018 | 3.87x | €12.11 Million | €46.90 Million | ▲ +470.9% |
| 2017 | 0.68x | €27.89 Million | €18.92 Million | ▲ +95.2% |
| 2016 | 0.35x | €21.12 Million | €7.34 Million | — |